40 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
, department, bureau, commission, council or other governmental entity whose review, approval or authorization is necessary for the Development
6-K
CNTB
Connect Biopharma Holdings Ltd
1 Nov 23
Current report (foreign)
3:57pm
, Connect Biopharma Holdings Limited (the “Company”) received written notice from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Current report (foreign)
6:13am
, 2023, Connect Biopharma Holdings Limited (the “Company”) received a letter from the Listings Qualifications Department of the Nasdaq Stock Market LLC
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
23 Jun 23
House Lease Contract
4:31pm
. Party B shall comply with other regulations of Party A’s management department.
7.8. Party B shall strictly abide by China’s laws and regulations
6-K
kp7xsvwcl 4t
2 Dec 22
Current report (foreign)
5:15pm
6-K
r5w14bzu sp9
19 Aug 22
Current report (foreign)
6:06am
6-K
u7lf1tplplws9znvq2v
17 Jun 22
Current report (foreign)
4:06pm
F-3
EX-1.2
86axbq1ydw7l1rmw58m4
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-4.12
h21i4u9md3u3s
31 Mar 22
Annual report (foreign)
4:33pm
20-F
gmvw9ozl
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
x9zzvigv4txgmwrr4o1
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
jcwplbgb1mnbn0ao f0b
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
ctw d9bx0hb
2 Sep 21
Connect Biopharma Announces First Patient Dosed in China Pivotal Trial
4:40pm
6-K
EX-99.1
u0s3x6 7mspne
17 May 21
Connect Biopharma Announces First
5:27pm
S-8
EX-4.3
95g qdn0vqsu7ac
19 Mar 21
Registration of securities for employees
5:13pm
424B4
yq83rr5vnsoc49
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
36p1cxx
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-10.4
pbj z5gka8
12 Mar 21
Registration statement (foreign) (amended)
5:02pm